Punt N - Search Results

1

Pharmacokinetic parameters over time during sepsis and the association of target attainment and outcomes in critically ill children and young adults receiving ceftriaxone.

Tang Girdwood S, Tang P, Fenchel M, Dong M, Stoneman E, Jones R, Ostermeier A, Curry C, Forton M, Hail T, Mullaney R, Diseroad E, Punt N, Kaplan J, Vinks AA. Tang Girdwood S, et al. Among authors: punt n. Pharmacotherapy. 2023 Jul;43(7):609-621. doi: 10.1002/phar.2774. Epub 2023 Feb 14. Pharmacotherapy. 2023. PMID: 36727212 Free PMC article.

2

Model-informed Precision Dosing for Biologics Is Now Available at the Bedside for Patients With Inflammatory Bowel Disease.

Colman RJ, Samuels A, Mizuno T, Punt N, Vinks AA, Minar P. Colman RJ, et al. Among authors: punt n. Inflamm Bowel Dis. 2023 Aug 1;29(8):1342-1346. doi: 10.1093/ibd/izac237. Inflamm Bowel Dis. 2023. PMID: 36413113 Free PMC article.

3

Ruxolitinib Pharmacokinetics and Pharmacodynamics in Children with Acute and Chronic Graft-versus-Host Disease.

Cook E, Dong M, Chiang SCC, Luedeke D, Lake KE, Hoerth C, Deavy M, Setchell KDR, Zhao J, Punt N, Galletta T, Teusink-Cross A, Davies SM, Marsh RA, Mehta P, Khandelwal P. Cook E, et al. Among authors: punt n. Transplant Cell Ther. 2024 May;30(5):528.e1-528.e12. doi: 10.1016/j.jtct.2024.02.018. Epub 2024 Feb 22. Transplant Cell Ther. 2024. PMID: 38401793

4

High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder: A Case Series.

Westerkamp AC, Pereira RR, Huitema VR, Kouwert EAM, Matic M, van Schaik RHN, Punt N, Schoevers RA, Touw DJ. Westerkamp AC, et al. Among authors: punt n. J Clin Psychopharmacol. 2024 Jan-Feb 01;44(1):35-38. doi: 10.1097/JCP.0000000000001772. Epub 2023 Oct 17. J Clin Psychopharmacol. 2024. PMID: 37851403

5

Rationale, Development, and Validation of HdxSim, a Clinical Decision Support Tool for Model-Informed Precision Dosing of Hydroxyurea for Children with Sickle Cell Anemia.

Power-Hays A, Dong M, Punt N, Mizuno T, Smart LR, Vinks AA, Ware RE. Power-Hays A, et al. Among authors: punt n. Clin Pharmacol Ther. 2023 Nov 28. doi: 10.1002/cpt.3119. Online ahead of print. Clin Pharmacol Ther. 2023. PMID: 38018175

6

Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for subacute and chronic staphylococcal infections.

Cojutti PG, Gatti M, Punt N, Douša J, Zamparini E, Tedeschi S, Viale P, Pea F. Cojutti PG, et al. Among authors: punt n. Int J Antimicrob Agents. 2024 Jan;63(1):107038. doi: 10.1016/j.ijantimicag.2023.107038. Epub 2023 Nov 21. Int J Antimicrob Agents. 2024. PMID: 37981075

7

Tutorial on model selection and validation of model input into precision dosing software for model-informed precision dosing.

Taylor ZL, Poweleit EA, Paice K, Somers KM, Pavia K, Vinks AA, Punt N, Mizuno T, Girdwood ST. Taylor ZL, et al. Among authors: punt n. CPT Pharmacometrics Syst Pharmacol. 2023 Dec;12(12):1827-1845. doi: 10.1002/psp4.13056. Epub 2023 Oct 12. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37771190 Free PMC article.

8

Cefepime pharmacokinetics in critically ill children and young adults undergoing continuous kidney replacement therapy.

Pavia K, Hambrick HR, Paice K, Tang P, Punt N, Kaplan J, Goldstein SL, Vinks AA, Mizuno T, Tang Girdwood S. Pavia K, et al. Among authors: punt n. J Antimicrob Chemother. 2023 Sep 5;78(9):2140-2147. doi: 10.1093/jac/dkad192. J Antimicrob Chemother. 2023. PMID: 37466170

9

Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study.

Meenks SD, Punt N, le Noble JLML, Foudraine NA, Neef K, Janssen PKC. Meenks SD, et al. Among authors: punt n. Crit Care. 2023 Mar 3;27(1):82. doi: 10.1186/s13054-023-04353-5. Crit Care. 2023. PMID: 36869388 Free PMC article.

10

Voriconazole exposure is influenced by inflammation: A population pharmacokinetic model.

van den Born DA, Märtson AG, Veringa A, Punt NC, van der Werf TS, Alffenaar JC, Sturkenboom MGG, Touw DJ. van den Born DA, et al. Among authors: punt nc. Int J Antimicrob Agents. 2023 Apr;61(4):106750. doi: 10.1016/j.ijantimicag.2023.106750. Epub 2023 Feb 8. Int J Antimicrob Agents. 2023. PMID: 36758777 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page